Shen Gu

514 total citations
17 papers, 402 citations indexed

About

Shen Gu is a scholar working on Molecular Biology, Cancer Research and Surgery. According to data from OpenAlex, Shen Gu has authored 17 papers receiving a total of 402 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 9 papers in Cancer Research and 4 papers in Surgery. Recurrent topics in Shen Gu's work include MicroRNA in disease regulation (5 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (4 papers) and Genetic and Kidney Cyst Diseases (4 papers). Shen Gu is often cited by papers focused on MicroRNA in disease regulation (5 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (4 papers) and Genetic and Kidney Cyst Diseases (4 papers). Shen Gu collaborates with scholars based in China, Sweden and United States. Shen Gu's co-authors include Xiaodong Han, Huaner Ni, Weifeng Li, Yue Wang, Shuang Xu, Yang Chen, Fang Wang, Ying Zhuge, Zou Xiang and Hui Zhao and has published in prestigious journals such as Circulation Research, Scientific Reports and Biochemical and Biophysical Research Communications.

In The Last Decade

Shen Gu

16 papers receiving 398 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Shen Gu China	9	193	158	107	69	64	17	402
Yurong Gu China	16	194 1.0×	141 0.9×	157 1.5×	40 0.6×	223 3.5×	63	750
Markus Stark Germany	10	207 1.1×	85 0.5×	32 0.3×	31 0.4×	50 0.8×	11	551
Kinya Inoue Japan	10	88 0.5×	88 0.6×	219 2.0×	8 0.1×	124 1.9×	16	416
Linping Cao China	11	150 0.8×	129 0.8×	28 0.3×	68 1.0×	40 0.6×	25	379
Helen Marshall United Kingdom	8	112 0.6×	17 0.1×	127 1.2×	36 0.5×	182 2.8×	10	525
Francesca Vulcano Italy	9	120 0.6×	45 0.3×	40 0.4×	8 0.1×	41 0.6×	18	445
Haixiang Qin China	13	477 2.5×	419 2.7×	7 0.1×	43 0.6×	39 0.6×	23	692
Ilona Urbárová Norway	9	103 0.5×	73 0.5×	11 0.1×	10 0.1×	61 1.0×	18	523
Eleftheria Tsolaki Greece	7	38 0.2×	30 0.2×	71 0.7×	21 0.3×	62 1.0×	19	184
Qinghua Qi China	10	103 0.5×	77 0.5×	52 0.5×	4 0.1×	20 0.3×	32	334

Countries citing papers authored by Shen Gu

Since Specialization

Citations

This map shows the geographic impact of Shen Gu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shen Gu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shen Gu more than expected).

Fields of papers citing papers by Shen Gu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shen Gu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shen Gu. The network helps show where Shen Gu may publish in the future.

Co-authorship network of co-authors of Shen Gu

This figure shows the co-authorship network connecting the top 25 collaborators of Shen Gu. A scholar is included among the top collaborators of Shen Gu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shen Gu. Shen Gu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

17 of 17 papers shown

Ni, Huaner, Ying Zhuge, Weifeng Li, et al.. (2025). LncRNA MIR181A1HG Deficiency Attenuates Vascular Inflammation and Atherosclerosis. Circulation Research. 136(8). 862–883. 4 indexed citations

Gu, Shen, Weining Wu, Chao Wu, et al.. (2025). RBMS1 promotes the proliferation of glioma cells via regulation of the c-Myc–SSH1 axis. Biochemical and Biophysical Research Communications. 758. 151586–151586.

Gu, Shen, et al.. (2022). Microcystin-LR in Primary Liver Cancers: An Overview. Toxins. 14(10). 715–715. 26 indexed citations

Gu, Shen, Minghao Yan, Cong Wang, et al.. (2020). Microcystin-leucine-arginine induces liver fibrosis by activating the Hedgehog pathway in hepatic stellate cells. Biochemical and Biophysical Research Communications. 533(4). 770–778. 18 indexed citations

Li, Weifeng, Yue Wang, Yunfei Deng, et al.. (2020). Epigenetic Control of circHNRNPH1 in Postischemic Myocardial Fibrosis through Targeting of TGF-β Receptor Type I. Molecular Therapy — Nucleic Acids. 25. 93–104. 11 indexed citations

Gu, Shen, Wei He, Minghao Yan, et al.. (2020). Higher content of microcystin‐leucine‐arginine promotes the survival of intrahepatic cholangiocarcinoma cells via regulating SET resulting in the poorer prognosis of patients. Cell Proliferation. 54(2). e12961–e12961. 3 indexed citations

Zhao, Hui, Wenzhou Ding, Hong Wang, et al.. (2020). Prognostic value of precise hepatic pedicle dissection in anatomical resection for patients with hepatocellular carcinoma. Medicine. 99(10). e19475–e19475. 6 indexed citations

Gu, Shen, Jun Chen, Qun Zhou, et al.. (2019). LRRK2 Is Associated with Recurrence-Free Survival in Intrahepatic Cholangiocarcinoma and Downregulation of LRRK2 Suppresses Tumor Progress In Vitro. Digestive Diseases and Sciences. 65(2). 500–508. 7 indexed citations

Yan, Minghao, Shen Gu, Yuan Zhou, Xiannan Meng, & Xiaodong Han. (2019). The role of ERK-RSK signaling in the proliferation of intrahepatic biliary epithelial cells exposed to microcystin-leucine arginine. Biochemical and Biophysical Research Communications. 521(2). 492–498. 9 indexed citations

10.

Ni, Huaner, Weifeng Li, Ying Zhuge, et al.. (2019). Inhibition of circHIPK3 prevents angiotensin II-induced cardiac fibrosis by sponging miR-29b-3p. International Journal of Cardiology. 292. 188–196. 116 indexed citations

11.

Song, Hongtao, Li Hy, Jing Ma, et al.. (2019). Characterization of hsa_circ_0000594 as a new biomarker and therapeutic target for hepatoblastoma.. PubMed. 23(19). 8274–8286. 8 indexed citations

12.

Gu, Shen, et al.. (2018). [Clinical analysis of seven cases of rare hemolytic disease of the newborn].. PubMed. 56(5). 369–372. 1 indexed citations

13.

Yan, Xiaopeng, Chuang Chen, Shen Gu, et al.. (2017). Mutation Detection of Fibroblast Growth Factor Receptor 3 for Infiltrative Hepatocellular Carcinoma by Whole-Exome Sequencing. Digestive Diseases and Sciences. 62(2). 407–417. 5 indexed citations

14.

Zhao, Hui, et al.. (2017). Prognostic value and preoperative predictors of microvascular invasion in solitary hepatocellular carcinoma ≤ 5 cm without macrovascular invasion. Oncotarget. 8(37). 61203–61214. 31 indexed citations

15.

Wang, Cong, Shen Gu, Honghui Cao, et al.. (2016). miR-877-3p targets Smad7 and is associated with myofibroblast differentiation and bleomycin-induced lung fibrosis. Scientific Reports. 6(1). 30122–30122. 52 indexed citations

16.

Wang, Cong, Shen Gu, Zou Xiang, et al.. (2016). The toxic effects of microcystin-LR on mouse lungs and alveolar type II epithelial cells. Toxicon. 115. 81–88. 35 indexed citations

17.

Zhao, Hui, Chuang Chen, Shen Gu, et al.. (2016). Anatomical versus non‐anatomical resection for solitary hepatocellular carcinoma without macroscopic vascular invasion: A propensity score matching analysis. Journal of Gastroenterology and Hepatology. 32(4). 870–878. 70 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact